Search Orphan Drug Designations and Approvals
-
Generic Name: | bucillamine |
---|---|
Date Designated: | 10/22/2015 |
Orphan Designation: | Treatment of cystinuria |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Revive Therapeutics, Ltd. 5 Director Court Suite 105 Vaughan Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-